Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schlaak

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
European Radiology|April 7, 2022
Two-dimensional CT measurements enable assessment of body composition on head and neck CTDavid Zopfs, Daniel Pinto Dos Santos, Jonathan Kottlors, et al.
The Journal of Experimental Medicine|January 19, 2017
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanomaMelina Mescher, Peter Jeong, Sina K Knapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Journal for Immunotherapy of Cancer|September 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitisKim Nikola Oliva, Lisa Arnold, Lucie Heinzerling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 19, 2013
Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas"Rose K C Moritz, Markus Ditschkowski, Claus-Detlev Klemke, et al.
International Journal of Molecular Sciences|September 13, 2018
Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 TreatmentMaike Trommer-Nestler, Simone Marnitz, Martin Kocher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Pharmacology|February 22, 2020
Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Frontiers in Pharmacology|June 4, 2019
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
European Radiology|April 7, 2022
Two-dimensional CT measurements enable assessment of body composition on head and neck CTDavid Zopfs, Daniel Pinto Dos Santos, Jonathan Kottlors, et al.
The Journal of Experimental Medicine|January 19, 2017
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanomaMelina Mescher, Peter Jeong, Sina K Knapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Journal for Immunotherapy of Cancer|September 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitisKim Nikola Oliva, Lisa Arnold, Lucie Heinzerling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 19, 2013
Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas"Rose K C Moritz, Markus Ditschkowski, Claus-Detlev Klemke, et al.
International Journal of Molecular Sciences|September 13, 2018
Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 TreatmentMaike Trommer-Nestler, Simone Marnitz, Martin Kocher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Pharmacology|February 22, 2020
Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Frontiers in Pharmacology|June 4, 2019
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Pageof 10